Kawaguchi, Kei <br/><br/>
Tumor-Targeting Salmonella typhimurium A1-R Sensitizes Melanoma With a BRAF-V600E Mutation to Vemurafenib in a Patient-Derived Orthotopic Xenograft (PDOX) Nude Mouse Model.  [electronic resource] 

 -  Journal of cellular biochemistry  08 2017 
 - 2314-2319 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1097-4644 
<br/><br/><label>Standard No.: </label>10.1002/jcb.25886  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Animals<br/>Azetidines--therapeutic use<br/>Cell Line, Tumor<br/>Disease Models, Animal<br/>Female<br/>Humans<br/>Indoles--therapeutic use<br/>Melanoma--drug therapy<br/>Mice<br/>Mice, Nude<br/>Microscopy, Confocal<br/>Microscopy, Electron, Transmission<br/>Mutation--genetics<br/>Piperidines--therapeutic use<br/>Proto-Oncogene Proteins B-raf--genetics<br/>Pyridones--therapeutic use<br/>Pyrimidinones--therapeutic use<br/>Salmonella typhimurium--genetics<br/>Sulfonamides--therapeutic use<br/>Vemurafenib<br/>Xenograft Model Antitumor Assays